DCSIMG
3 Segment information - Annual Report 2015 - DSM

3 Segment information

Table 1: Geographical information

Geographical information
2014
Continuing operations
 
The Nether-lands
Rest of Western Europe
Eastern Europe
North America
Latin America
China
India
Japan
Rest of Asia
Rest of the world
Total
Net sales by origin
                     
In € million
1,982
2,033
122
1,160
675
636
54
72
253
64
7,051
In %
28
29
2
16
9
9
1
1
4
1
100
                       
Net sales by destination
                     
In € million
302
1,818
437
1,546
951
833
133
203
617
211
7,051
In %
4
26
6
22
13
12
2
3
9
3
100
                       
Workforce at year-end (headcount)
4,372
4,697
404
3,299
1,891
2,639
478
141
866
240
19,027
                       
Intangible assets and Property, plant and equipment
                     
Capital expenditure
153
131
2
97
19
61
6
-
6
2
477
Carrying amount
1,402
1,201
31
2,324
353
373
18
20
144
22
5,888
                       
Total assets (total DSM)
3,709
2,110
113
3,323
820
1,458
70
88
359
76
12,126
                       
2015
 
Net sales by origin
                     
In € million
1,938
2,123
154
1,451
719
837
76
73
272
79
7,722
In %
25
27
2
19
9
11
1
1
4
1
100
                       
Net sales by destination
                     
In € million
280
1,851
467
1,779
1,053
937
153
209
740
253
7,722
In %
4
24
6
23
14
12
2
3
9
3
100
                       
Workforce at year-end (headcount)
4,190
4,682
426
3,151
2,021
4,551
521
145
811
252
20,750
                       
Intangible assets and Property, plant and equipment
                     
Capital expenditure
138
121
2
102
22
84
2
-
5
2
478
Carrying amount
1,619
1,238
29
2,537
292
505
19
22
117
21
6,399
                       
Total assets (total DSM)
3,838
2,038
119
3,486
749
882
82
95
361
93
11,743

DSM has no single external customer that represents 10% or more of revenues and therefore information about major customers is not provided.

Table 2: Business segments

Business segments1
2015
Continuing operations
Discon-
tinued operations
Elimina-
tions
Total
Nutrition
Perform-
ance Materials
Innovation Center
Corporate
Activities2
Elimina-
tions
Total
Financial performance
                 
Net sales
4,963
2,528
155
76
-
7,722
1,213
-
8,935
Supplies to other clusters
56
19
3
-
(61)
17
253
(270)
-
                   
Supplies
5,019
2,547
158
76
(61)
7,739
1,466
(270)
8,935
                   
EBITDA
822
384
(9)
(122)
-
1,075
95
-
1,170
Operating profit
535
250
(43)
(169)
-
573
77
-
650
Exceptional items
(40)
(65)
(23)
(83)
-
(211)
(135)
-
(346)
                   
Operating profit including exceptional items
495
185
(66)
(252)
-
362
(58)
-
304
                   
Depreciation and amortization
271
133
28
43
-
475
13
-
488
Impairments
16
1
6
4
-
27
5
-
32
Impairments in exceptional items
9
60
5
18
-
92
130
-
222
Additions to provisions
3
23
-
55
-
81
1
-
82
Share of the profit of associates and joint ventures
-
3
(18)
45
-
30
-
-
30
R&D costs3
123
109
70
28
-
330
8
-
338
Wages, salaries and social security costs
859
319
71
318
-
1,567
82
-
1,649
                   
Financial position
                 
Total assets
6,523
2,122
809
2,289
-
11,743
-
-
11,743
Total liabilities
1,755
791
77
3,489
-
6,112
-
-
6,112
Capital employed at year-end
5,309
1,723
560
(39)
-
7,553
-
-
7,553
Capital expenditure
322
98
34
24
-
478
92
-
570
Share in equity of associates and joint ventures
1
7
135
501
-
644
-
-
644
                   
EBITDA / net sales (in %)
16.6
15.2
     
13.9
7.8
 
13.1
                   
Workforce
                 
Average in FTE
12,903
4,450
551
2,677
-
20,581
1,238
-
21,819
Year-end (headcount)
12,930
4,477
556
2,787
-
20,750
-
-
20,750
1 For a description of the types of products and services of each segment please refer to the 'Review of business' in the 'Report by the Managing Board'. Supplies from DSM Fibre Intermediates to DSM Engineering Plastics were executed at cost until deconsolidation. Transfers between other segments were fairly limited and were generally executed at market-based prices.
2 Corporate Activities also includes costs for regional holdings, corporate overhead and share-based compensation.
3 R&D costs relate to the functional area Research and development and exclude R&D cost included in the functional areas Cost of sales and Marketing and sales as well as R&D expenditure capitalized.

Table 3: Business segments

Business segments1
2014
Continuing operations
Discon-
tinued
operations
Elimina-tions
Total
Nutrition
Perform-ance
Materials
Innovation Center
Corporate Activities 2
Elimina-tions
Total
Financial performance
                 
Net sales
4,335
2,460
154
102
-
7,051
2,232
-
9,283
Supplies to other clusters
92
38
3
-
(95)
38
415
(453)
-
                   
Supplies
4,427
2,498
157
102
(95)
7,089
2,647
(453)
9,283
                   
EBITDA
850
323
(18)
(117)
-
1,038
128
-
1,166
Operating profit
596
204
(45)
(168)
-
587
30
-
617
Exceptional items
(23)
4
-
(41)
-
(60)
(267)
-
(327)
                   
Operating profit including exceptional items
573
208
(45)
(209)
-
527
(237)
-
290
                   
Depreciation and amortization
242
118
27
46
-
433
87
-
520
Impairments
12
1
-
5
-
18
11
-
29
Impairments in exceptional items
1
(1)
-
3
-
3
294
-
297
Additions to provisions
29
-
-
22
-
51
4
-
55
Share of the profit of associates and joint ventures
(1)
2
(10)
(48)
-
(57)
(2)
-
(59)
R&D costs3
103
98
70
33
-
304
19
-
323
Wages, salaries and social security costs
818
304
67
245
-
1,434
163
-
1,597
                   
Financial position
                 
Total assets
6,200
1,835
750
2,012
-
10,797
1,329
-
12,126
Total liabilities
1,541
529
68
3,379
-
5,517
673
-
6,190
Capital employed at year-end
5,034
1,744
523
130
-
7,431
674
-
8,105
Capital expenditure
330
71
27
49
-
477
139
-
616
Share in equity of associates and joint ventures
1
6
118
482
-
607
10
-
617
                   
EBITDA / net sales (in %)
19.6
13.1
     
14.7
5.7
 
12.6
                   
Workforce
                 
Average in FTE
11,067
4,476
697
2,830
-
19,070
2,728
-
21,798
Year-end (headcount)
10,857
4,496
675
2,999
-
19,027
2,324
-
21,351
1 For a description of the types of products and services of each segment please refer to the 'Review of business' in the 'Report by the Managing Board'. Supplies from DSM Fibre Intermediates to DSM Engineering Plastics were executed at cost. Transfers between other segments were fairly limited and were generally executed at market-based prices.
2 Corporate Activities also includes costs for regional holdings, corporate overhead and share-based compensation.
3 R&D costs relate to the functional area Research and development and exclude R&D costs included in the functional areas Cost of sales and Marketing and sales as well as R&D expenditure capitalized.